Fertility Insights

In the first episode of this two-part podcast, Jenna Miller, MS, CGC, Senior Clinical Science Specialist, speaks with Elizabeth Cameron, MS, CGC Director of International and Operational Genetic Counseling and Dina Nusblat, MS, CGC, Lab genetic counsellor, about ASRM’s Genetic Counseling Professional Groups most recent committee opinion: Indications and management for preimplantation genetic testing for monogenic conditions. Elizabeth explores the reasons behind the increased update of PGT-M testing. Dina explains the ASRM professional counselling group and its goal to guide other genetic counsellors and professionals in the ART field. To learn more about our international team of genetic counsellors, you can head to: https://fertility.coopersurgical.com/genomics/genetic-counseling/To download and read the committee opinion, you can head to: https://www.sciencedirect.com/science/article/pii/S0015028223002108?dgcid=author

Bruce and Jim's journey to parenthood was a rollercoaster ride of challenge and ultimate triumph. From battling societal norms to navigating the complex world of IVF and surrogacy.Their story is a testament to their unwavering passion, patience, and perseverance, which paid off in the form of their dream reward: two healthy babies to call their own.CooperSurgical® employee, Bruce addresses the insufficient resources that underrepresented communities could face in accessing direct support and encouragement during the IVF process. He hopes that sharing this story will empower same-sex families who are considering or undergoing IVF, reminding them: 'you can do this!'

Join us live at PGDIS 2023 with our genomics experts Colleen Lynch, Tony Gordon and Lauren Isley as they discuss the research presented and their main conference highlights. Lauren discusses the use of PGT-M for monogenic disease plus HLA compatibility, and Colleen about her work on the analysis of incidental aneuploidy in PGT-SR trophectoderm biopsy samples, exploring if there is a link or not to inter-chromosomal effect.Tony speaks about the exciting sessions he attended, including updates on the data presented from the mosaicism registry. Enjoy this episode recorded live from the conference venue!

IVF mix-ups are rare, but they do happen and can lead to devastating consequences for families and clinics. We spoke with Scientific Director, Denny Sakkas and Lab Director, Alyssa Jones to address patient anxiety around mix-ups. We discussed how the Parental QC feature (part of our PGT-Complete℠ test) combined with an electronic witnessing system like RI Witness™ can provide clinics with a solution to help minimize IVF mix-ups.Please note that both speakers were paid to take part in this episode and the views expressed by our guests are their own, and their appearance on the program does not imply an endorsement of them or any entity they represent.

For the first episode of 2023, we explore the latest publications in genomics, deep diving into the patient groups involved and the clinical impact of the studies.

Mollie Erskine, Genomics Communication Manager is in conversation with pioneer in reproductive medicine, Mark Hughes, MD, PhD live from ASRM where he was awarded a lifetime achievement award. Mark talks to us about his career and how he combined his passions and education to move the field of preimplantation genetic testing forward and ultimately help families to have healthy children.

Mollie Erskine, Genomics Communication Manager, talks to Johan Sterckx, Quality manager ART lab and Neelke De Munck, PhD, Head of the ART lab at Brussels IVF, about their research presented at ESHRE 2022: Ten years electronic witnessing in the IVF laboratory. 

Listen to our podcast recorded live at ESHRE 2022! As our sponsored symposium focused on advancing the future of fertility care and the future of ART, in part two, Mollie Erskine, Genomics Communication Manager, asks how guests David Morroll, PhD and Steven Fleming, PhD, have seen the field change during their careers and how the research presented at ESHRE inspires them for the future of the industry.